Skip to Content
  • Previous Rank507
  • Revenues ($M)$5,825.0
  • Revenue Percent Change9.8%
  • Profits ($M)$1,428.0
  • Profits Percent Change65.3%
  • Assets ($M)$10,777.0
  • Employees10,000

Zoetis develops and manufactures animal health medicines and vaccines that aim to help veterinarians, as well as livestock farmers.

Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

Company Info

Juan Ram�n Alaix
CEO Title
Chief Executive Officer & Director
Health Care
HQ Location
Parsippany, N.J.
Years on Fortune 500 List1

Zoetis Rank History

Key Financials (Last Fiscal Year)

$ millions% change
Revenues ($M)$5,825.09.8%
Profits ($M)$1,428.065.3%
Assets ($M)$10,777.0-
Total Stockholder Equity ($M)$2,185.0-

Profit Ratios

Profit as % of Revenues24.5%
Profits as % of Assets13.3%
Profits as % of Stockholder Equity65.4%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)2.93
EPS % Change (from 2017)67.4%
EPS % Change (5 year annual rate)23.7%
EPS % Change (10 year annual rate)-

Total Return

Total Return to Investors (2018)19.4%
Total Return to Investors (5 year, annualized)22.1%
Total Return to Investors (10 year, annualized)-